Business Editors/Hi-Tech Writers
PHILADELPHIA--(BUSINESS WIRE)--Sept. 26, 2000
On this week's edition of "Roth Capital Partners and the New Economy," Fariba Ghodsian, Managing Director and Director of Healthcare Research of Roth Capital Partners, discusses Miravant Medical Technologies (NASDAQ:MRVT), Alliance Pharmaceutical Corp. (NASDSAQ:ALLP) and Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX).
This event is now available for on demand listening. To listen, visit http://www.radiowallstreet.com. After September 26, 2000, access via this direct link http://www.radiowallstreet.com/NASApp/RWS/EventPage?ID=41970. First time listeners may need to download audio software via the RadioWallStreet.com website.
There is no charge to access any RadioWallStreet.com event. Questions related to this event may be submitted to patricia@radiowallstreet.com. Please reference date and time of the interview in the Subject of the e-mail.
About Investor Broadcast Network
Investor Broadcast Network is the leading broadcaster of real-time investment information and analysis on the Internet.
With a complete portfolio of web-based broadcast communication services, the company gives investors access to the inner circle of corporate executives and industry thought leaders, while providing public companies with an efficient online investor relations strategy that meets their financial needs and reduces the high-risk of selective disclosure.
For more information on Investor Broadcast Network visit www.investorbroadcast.com.

Комментариев нет:
Отправить комментарий